Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency and Safety of Sabin IPV in Infants
NCT04386707Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2020
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started May 2020; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04386707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04386707.